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Lack of Evidence for Attributing 
Chlorhexidine as the Main Active 
Ingredient in Skin Antiseptics Preventing 
Surgical Site Infections 
To the Editor—We read with great interest the articles by 
Noorani et al1 in the British Journal of Surgery and by Lee et 
al2 in Infection Control and Hospital Epidemiology. The authors 
have published almost simultaneously two systematic reviews 
of what is described as comparisons of chlorhexidine versus 
povidone-iodine for preoperative skin antisepsis. On the basis 
of their analyses, the authors conclude that chlorhexidine is 
the more effective antiseptic in preventing surgical site in-
fections (SSIs). However, we believe that this conclusion is 
not sufficiently supported by the studies included. 
In both articles, the effect of preventing SSIs is solely at-
tributed to chlorhexidine. However, the majority of studies 
were based on chlorhexidine-alcohol mixtures. When attrib-
uting effects to factors, it is necessary to look for other factors 
that could also be influencing these effects. The common 
agents for preoperative skin antisepsis are (1) alcohols, (2) 
chlorhexidine, and (3) povidone-iodine. Both chlorhexidine 
and povidone-iodine are available in aqueous formulations 
and in alcoholic formulations. Aqueous formulations have 1 
active ingredient, whereas alcoholic formulations include 2 
active ingredients. The differential antimicrobial activity of 
these compounds has been a topic of intense research and 
evaluation since the 1970s and is well described in infection 
control textbooks and guidelines.3'6 If aqueous chlorhexidine 
or povidone-iodine is compared with various alcohols, then 
the immediate antimicrobial activity of the alcohols is sig-
nificantly greater than that of the aqueous agents, by a factor 
of about 1 log (ie, a 10-fold difference). Alcohol is clearly a 
powerful skin antiseptic on its own, and in alcoholic chlor-
hexidine or povidone-iodine formulations it is the agent that 
contributes most to the overall activity. We have highlighted 
this in a previous letter to the editor.7 Formulations of al-
cohols with chlorhexidine or povidone-iodine may have some 
added activity or persistency, which pure alcohols do not 
have.6 
In our opinion, the articles by Noorani et al1 and Lee et 
al2 have not shown clear and unambiguous evidence that the 
observed effects are solely or even mainly due to chlorhex-
idine, despite this being the main claim put forward by the 
authors. At the same time, they ignore the effects that the 
alcohol in the antiseptics is likely to have had. Beyond the 
mere presence of chlorhexidine and povidone-iodine, the 
studies analyzed in both articles are very heterogeneous. Some 
compared alcoholic chlorhexidine with aqueous povidone-
iodine, one compared aqueous preparations in both study 
arms, and some compared alcoholic preparations in both 
arms. Some assessed SSI rates as the outcome, others (ana-
lyzed in Lee et al2) assessed skin microbial cultures after an-
tisepsis. One recent study with significantly different SSI rates 
as the outcome,8 contributing a large number of observations 
to the analyses, compared the use of alcoholic chlorhexidine 
to that of aqueous povidone-iodine, where the alcohol in the 
chlorhexidine formulation clearly confers an a priori advan-
tage. One study involved vaginal surgery exclusively. The sit-
uation for vaginal surgery is fundamentally different from 
surgery through superficial skin, since the physiology of mu-
cous membranes and the quality and quantity of the microbial 
flora are vastly different, and only aqueous preparations can 
be used. One earlier study from 1982 used alcoholic for-
mulations in both arms but did not specify the alcohol con-
centrations used and whether they were in the antimicrobially 
active range, which means that no conclusions can be drawn. 
None of the studies with microbial culture results as the end 
points used any US or European standardized methods for 
antiseptic or disinfectant testing. Also, it is important to note 
that none of these studies specified whether they used any 
neutralizer substances in the experiments. Neutralizers are 
essential for some antiseptic testing experiments because 
some antiseptics continue to kill microorganisms after sam-
pling, so that in the absence of neutralizers falsely higher kill 
rates will be seen.9 Chlorhexidine in particular appears to be 
prone to this effect, with falsely low colony counts being a 
consequence.9 
Our cautious guess is that if there were sufficient data 
available for a meta-analysis comparing alcoholic with aque-
ous skin antiseptics, the alcohol-based ones would probably 
fare very well. Just as well as being a study of chlorhexidine 
versus povidone-iodine, the article by Darouiche et al8 could 
have been labeled a study of an alcoholic versus an aqueous 
compound. Interestingly, a very large recent study using 1 
alcoholic chlorhexidine protocol and 2 alcohol-containing 
iodine preparation protocols,10 all with alcohol concentrations 
in the active range, showed a small but statistically significant 
advantage of the iodine-containing protocols. We conclude 
that based on the known properties of these different anti-
septics, alcohols should remain the primary component of 
surgical antiseptics for superficial skin, at least until further 
evidence becomes available. The efficacy of chlorhexidine ver-
sus iodine compounds should be determined under otherwise 
equivalent conditions, such as in sufficiently powered ran-
domized clinical trials comparing alcoholic formulations. 
This would ultimately resolve this important clinical question. 
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The Importance of Isopropyl Alcohol in 
Skin Preparation Solutions 
To the Editor—We read with great interest the recent article 
by Lee et al1 comparing chlorhexidine and iodine for skin 
antisepsis to prevent surgical site infection. We wish to com-
mend the authors for their timely execution and thoughtful 
approach to this analysis. 
We would like to contribute to this discussion by pointing 
out what we believe to be a very important aspect of the 
debate: the importance of isopropyl alcohol in solutions. Is-
opropyl alcohol (IPA) has been shown in both in vitro and 
in vivo studies to be a powerful and rapid antiseptic agent 
on the skin. According to many studies and texts on the 
subject, both chlorhexidine and iodine have an intermediate 
onset of action and a later peak effect, thus making the com-
bination of immediate action provided by IPA and delayed 
action in the mixed solutions theoretically superior to chlor-
hexidine and iodine alone. In their meta-analysis, the authors 
made no distinction between solutions containing IPA and 
those that did not contain this important agent when they 
drew the conclusion that chlorhexidine is superior to iodo-
phores. We present an argument against this conclusion. 
First we would like to discuss a large prospective study by 
our group that compared surgical site infection (SSI) rates 
during 3 separate 6-month time periods (spanning from Jan-
uary 1, 2006, to June 30, 2007) during which 3 different skin 
preparation protocols employing IPA were used for all adult 
general surgery cases at our institution.2 We found that rates 
of SSIs were significantly decreased when iodophore-based 
skin preparation solutions containing IPA were used, com-
pared with SSI rates when solutions of chlorhexidine plus 
IPA were used. Because all preparation protocols included 
IPA, we could isolate the nonalcohol component (chlorhex-
idine, iodine-providone, and iodine povacrylex were used in 
our study), and we concluded that iodine-based solutions 
were most likely superior to chlorhexidine-based solutions in 
both intention-to-treat and per-protocol models. 
Furthermore, when examining the studies used in the sys-
tematic review by Lee et al,1 we see that the authors found 
only 3 studies (Saltzman et al,3 Ostrander et al," and Veiga 
et al5) that compared iodophore solutions that contain alcohol 
with chlorhexidine solutions that contain alcohol. In these 
studies, the outcomes measured were positive skin swab cul-
tures and/or SSIs. In the Saltzman et al3 and Ostrander et al4 
studies, there were fewer positive skin swab cultures in the 
chlorhexidine group, but the SSI rates were not significantly 
different between the two groups. Only in the study by Veiga 
et al5 were they able to show a decrease in SSI rates in the 
chlorhexidine group. With the exception of the studies by 
Culligan et al6 (which compared 2 non-IPA-containing so-
lutions) and Berry et al5 (which contained a chlorhexidine-
plus-spirits solution), all of the other studies compared chlor-
hexidine plus IPA with iodophore agents that did not contain 
alcohol. We do not believe that this is a valid comparison. 
